Research Article
The Contribution of Drugs and Helicobacter pylori to Gastric Mucosa Changes in Patients with Systemic Lupus Erythematosus and Antiphospholipid Syndrome
Table 3
Detection rates of Helicobacter pylori, HSV-1, CMV, and their combinations in various gastric mucosal damages, as evidenced by esophagogastroduodenoscopy.
| |||||||||||||||||||||||||||||||||||||||||||||||||
Note: The percentage of positive results was calculated from the number of patients having an infectious agent. |